← Back to Search

Behavioural Intervention

Tai Chi for Cancer Survivors

Phase < 1
Waitlist Available
Led By Ce Shang, PhD
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months post-intervention
Awards & highlights

Study Summary

This trial looks at whether Tai Chi can help cancer survivors quit smoking. It is an ancient Chinese exercise that uses gentle movements, postures, and breathing to promote health. No meds or procedures involved.

Who is the study for?
This trial is for adult cancer survivors (21+ years old) who finished treatment at least 3 months ago and are current smokers with a moderate interest in quitting. They must be able to join Zoom calls. People not eligible include those treated for cancer within the last 3 months, under 21, unable to use Zoom, or have low interest in stopping smoking.Check my eligibility
What is being tested?
The study tests an online Tai Chi program designed to help cancer survivors quit smoking. It includes slow movements, posture exercises, meditation, and controlled breathing without medications or medical procedures. Participants will also undergo carbon monoxide measurement and surveys.See study design
What are the potential side effects?
Since Tai Chi is a non-invasive exercise with meditative aspects, it typically does not cause severe side effects. However, participants may experience mild discomfort like muscle soreness or fatigue from the physical activity.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
CO verification
Cigarette Dependence Scale (12 item)
Hospital Anxiety and Depression Scale
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (Tai Chi)Experimental Treatment6 Interventions
Participants receive access to the online WaQi program to practice Tai Chi supervised and home-based over 8 weeks. Participants also receive standard cessation treatment that includes a prescription or recommendation for NRT and CO testing on study.
Group II: Arm II (Standard cessation)Active Control6 Interventions
Participants receive standard cessation treatment that includes a prescription or recommendation for NRT and undergo CO testing on study. Participants also receive an 8-week online Tai Chi self-administered teaching module subscription at the end of the study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nicotine Replacement
2019
Completed Phase 2
~420

Find a Location

Who is running the clinical trial?

Ohio State University Comprehensive Cancer CenterLead Sponsor
320 Previous Clinical Trials
290,119 Total Patients Enrolled
Ce Shang, PhDPrincipal InvestigatorOhio State University Comprehensive Cancer Center

Media Library

Tai Chi (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05941858 — Phase < 1
Blood Cancers Research Study Groups: Arm I (Tai Chi), Arm II (Standard cessation)
Blood Cancers Clinical Trial 2023: Tai Chi Highlights & Side Effects. Trial Name: NCT05941858 — Phase < 1
Tai Chi (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05941858 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it still possible to sign up for this investigation?

"This trial, initially posted on July 1st 2023 and last updated on July 3rd 2023, is not accepting patient applications at this time. However, there are currently 2545 other medical trials actively searching for participants."

Answered by AI
~32 spots leftby Dec 2024